Associated Papers
OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor Necrosis Factor Inhibitor Therapy: A Rare Case Report.
Güngörer V et al.
The Journal of Rheumatology, 2025
Expanding the phenotypic and genetic spectrum of ORAS with novel homozygous variant in OTULIN gene: a case series and literature review.
AlSaleem A et al.
Pediatric Rheumatology Online Journal, 2025
OTULIN-related conditions: Report of a new case and review of the literature using GenIA.
Caballero-Oteyza A et al.
Clinical Immunology (orlando, Fla.), 2024
A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Takeda Y et al.
The Journal of Experimental Medicine, 2024
OTULIN-related conditions: Report of a new case and review of the literature using GenIA.
Caballero-Oteyza A et al.
Research Square, 2024
OTULIN deficiency: focus on innate immune system impairment.
Dou B et al.
Frontiers in Immunology, 2024
Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS.
Zinngrebe J et al.
Embo Molecular Medicine, 2022
Select a paper to view details